| Short Course Description |
Related Conference
|
Circulating Tumor Cells as Surrogate Endpoints in Clinical Trials
August 9, 2009 • Washington, DC
Program |
Register
Reality Check on Companion Diagnostics
August 9, 2009 • Washington, DC
Program | Register
Vaccine Business Opportunities
August 9, 2009 • Providence, RI
Program | Register
Managing Process Change in Vaccine Manufacturing
August 9, 2009 • Providence, RI
Program | Register
Optimizing Media: Achieving Super Soup
August 24, 2009 • Cambridge, MA
Program | Register
Publish or Perish? Common Pitfalls and Misconceptions Regarding Patents
August 24, 2009 • Cambridge, MA
Program | Register
'
Biomarker Assay Development and Validation
September 22, 2009 • Washington, DC
Program | Register
Next-Generation Technologies Enabling Personalized Medicine
September 22, 2009 • Washington, DC
Program | Register
Novel Cancer Biomarkers
September 22, 2009 • Washington, DC
Program | Register
Biomarker Validation
September 22, 2009 • Washington, DC
Program | Register
Sequencing Data Storage
October 5, 2009 • Hannover, Germany
Program | Register
Technical Advice on Assay Development, Validation and Sample Analysis 
October 26, 2009 • Philadelphia, PA
Program | Register
Strategies for Effective RNAi Screens 
November 1, 2009 • Boston, MA
Program | Register
Targeting GPCRs and Ion Channels with Antibodies 
November 1, 2009 • Boston, MA
Program | Register
Strategies for Optimizing RNAi Delivery 
November 1, 2009 • Boston, MA
Program | Register
Combating Diabetes with Strategies for Enhanced Pancreatic Beta Cell Survival and Regeneration 
November 1, 2009 • Boston, MA
Program | Register
Structure-Based Design of Ion Channels 
November 1, 2009 • Boston, MA
Program | Register
Cardiovascular Safety in Drug Development – From Preclinical to Phase I 
November 1, 2009 • Boston, MA
Program |
Register
Pragmatic Approaches to FDAAA: A Decision Tree Approach to Successful REMS Creation and Risk Assessment Studies
November 4, 2009 • Philadelphia, PA
Progam |
Register